Ahmed Abdelhakeem
Overview
Explore the profile of Ahmed Abdelhakeem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosalem O, Abdelhakeem A, Abdel-Razeq N, Babiker H
Expert Opin Investig Drugs
. 2025 Feb;
:1-12.
PMID: 40012027
Introduction: Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with limited therapeutic options and poor overall survival. In recent years, advances in genomic profiling have revealed the complex molecular...
2.
Anwar J, Arslan H, Sarfraz Z, Shuroog J, Abdelhakeem A, Saeed A, et al.
Curr Oncol
. 2024 Nov;
31(11):7204-7225.
PMID: 39590162
: Hepatocellular carcinoma (HCC) is a prevalent liver cancer with poor prognosis, often linked to hepatitis B (HBV) and C (HCV) infections. This meta-analysis evaluates the efficacy of immunotherapy in...
3.
Anwar J, Amin T, Sarfraz Z, Khalid M, Khan M, Abdelhakeem A
Proc (Bayl Univ Med Cent)
. 2024 Aug;
37(5):870-873.
PMID: 39165824
The choroid, rich in vasculature, is a common site for ocular metastases, predominantly from breast and lung cancer. Unlike breast cancer, which may cause bilateral involvement, lung cancer typically leads...
4.
Anwar J, Thompson J, Sarfraz Z, Terro T, Henry S, Blevins S, et al.
Proc (Bayl Univ Med Cent)
. 2024 Aug;
37(5):782-793.
PMID: 39165799
Background: Gastrointestinal (GI) cancers are the third leading cause of cancer-related mortality worldwide. Disparities in healthcare frequently stem from variations in socioeconomic status (SES). This study investigated the influence of...
5.
Sewastjanow-Silva M, Kwiatkowski E, Yamashita K, Abdelhakeem A, Yoshimura K, Vicentini E, et al.
Int J Cancer
. 2024 Jul;
155(12):2277-2286.
PMID: 38995150
Human epidermal growth factor receptor-2 (HER2), programmed death-ligand 1 (PD-L1), and microsatellite (MS) status are well-established biomarkers in gastroesophageal adenocarcinomas (GEAs). However, it is unclear how the combination of these...
6.
Waters R, Sewastjanow-Silva M, Yamashita K, Abdelhakeem A, Iwata K, Moran D, et al.
JCO Precis Oncol
. 2024 May;
8:e2300543.
PMID: 38781542
Purpose: Claudin 18 isoform 2 (CLDN18.2) is an emerging biomarker and therapeutic target in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma. This study aimed to obtain deeper understanding of CLDN18.2 positivity...
7.
Anwar J, Abdelhakeem A, Khan M, Arslan H, Shuroog J, Sarfraz Z, et al.
J Gastrointest Cancer
. 2024 May;
55(3):1004-1025.
PMID: 38748352
Background: Stage IV gastric cancer patients with Krukenberg tumors typically exhibit poor survival outcomes, often less than 2 years. The management of this tumor subgroup remains non-standardized, and the impact...
8.
Abouzid M, Abdelhakeem A, Elshafie S, Ghorab A
BMJ Case Rep
. 2024 Apr;
17(4).
PMID: 38631812
We present the case of an elderly man with a history of diastolic congestive heart failure, severe aortic stenosis and atrial fibrillation, who presented with fatigue, weakness, coffee ground emesis...
9.
Zou G, Anwar J, Pizzi M, Abdelhakeem A
J Thorac Dis
. 2024 Mar;
16(2):826-828.
PMID: 38505072
No abstract available.
10.
Hatia R, Eluri M, Hawk E, Shalaby A, Karatas E, Shalaby A, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Aug;
32(10):1338-1347.
PMID: 37540502
Background: It is estimated that 6% to 20% of all cholangiocarcinoma (CCA) diagnoses are explained by primary sclerosing cholangitis (PSC), but the underlying risk factors in the absence of PSC...